Yoh M et al. |
Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. |
1999 |
Can. J. Microbiol. |
pmid:10526400
|
Sato A et al. |
Effects of organic anions and vinblastine on biliary excretion of erythromycin in rats. |
1999 |
Pharmacology |
pmid:10529657
|
Janier M |
[Syphilis (except congenital syphilis)]. |
1999 Aug-Sep |
Ann Dermatol Venereol |
pmid:10530355
|
Schmidtke LM and Carson J |
Induction, characterisation and pathogenicity in rainbow trout Oncorhynchus mykiss (Walbaum) of Lactococcus garvieae L-forms. |
1999 |
Vet. Microbiol. |
pmid:10535774
|
Tobback K et al. |
Micellar electrokinetic capillary chromatography of macrolide antibiotics. Separation of tylosin, erythromycin and their related substances. |
1999 |
J Chromatogr A |
pmid:10536850
|
Maeda K et al. |
[A case of common variable immunodeficiency that responded to long-term erythromycin chemotherapy]. |
1999 |
Nihon Kokyuki Gakkai Zasshi |
pmid:10540836
|
Aoki Y and Kao PN |
Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543746
|
Netherwood T et al. |
Probiotics shown to change bacterial community structure in the avian gastrointestinal tract. |
1999 |
Appl. Environ. Microbiol. |
pmid:10543832
|
Jobe DA et al. |
Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents. |
1999 |
Clin. Diagn. Lab. Immunol. |
pmid:10548588
|
Watanabe M et al. |
Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo. |
1999 |
Xenobiotica |
pmid:10553724
|
Malonza IM et al. |
A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. |
1999 |
J. Infect. Dis. |
pmid:10558945
|
Reeves AR et al. |
Transcriptional organization of the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea. |
1999 |
J. Bacteriol. |
pmid:10559177
|
Denis A et al. |
Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. |
1999 |
Bioorg. Med. Chem. Lett. |
pmid:10560728
|
Bauer JF et al. |
Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation. |
1999 |
J Pharm Sci |
pmid:10564073
|
Morel P et al. |
Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris. |
1999 |
Clin. Exp. Dermatol. |
pmid:10564319
|
Matsuoka M et al. |
Cloning and sequences of inducible and constitutive macrolide resistance genes in Staphylococcus aureus that correspond to an ABC transporter. |
1999 |
FEMS Microbiol. Lett. |
pmid:10564793
|
Menezes CM et al. |
In vitro evaluation of erythromycin in chloroquine resistant brazilian P. falciparum freshly isolates: modulating effect and antimalarial activity evidence. |
1999 Jul-Aug |
Rev. Inst. Med. Trop. Sao Paulo |
pmid:10564920
|
Melo-Cristino J and Fernandes ML |
Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens. |
1999 |
Microb. Drug Resist. |
pmid:10566873
|
Clarke AE et al. |
Interaction of bile with erythromycin Lactobionate in vitro. |
1975 |
Aust N Z J Med |
pmid:1057910
|
Peng L and Nimni ME |
Delivery of erythromycin to subcutaneous tissues in rats by means of a trans-phase delivery system. |
1999 |
J. Pharm. Pharmacol. |
pmid:10579684
|
Brown MS et al. |
Production of 6-deoxy-13-cyclopropyl-erythromycin B by Saccharopolyspora erythraea NRRL 18643. |
1999 |
J. Antibiot. |
pmid:10580387
|
Klausner MA |
Astemizole use with erythromycin. |
1999 |
Ann. Allergy Asthma Immunol. |
pmid:10582723
|
Zarazaga M et al. |
In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582908
|
McCrea J et al. |
Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity. |
1999 |
J Clin Pharmacol |
pmid:10586386
|
Durak H et al. |
Tc-99m erythromycin lactobionate inhalation scintigraphy in parenchymal lung diseases. |
1999 |
Nucl. Med. Biol. |
pmid:10587109
|
Varaldo PE et al. |
Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group. |
1999 |
Clin. Infect. Dis. |
pmid:10589905
|
Glass D et al. |
A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris. |
1999 |
Dermatology (Basel) |
pmid:10592405
|
Brixius B et al. |
[Ventricular tachycardia after erythromycin administration in a newborn with congenital AV-block]. |
1999 Nov-Dec |
Klin Padiatr |
pmid:10592929
|
Damkier P et al. |
Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine. |
1999 |
Br J Clin Pharmacol |
pmid:10594487
|
Doumith M et al. |
Interspecies complementation in Saccharopolyspora erythraea : elucidation of the function of oleP1, oleG1 and oleG2 from the oleandomycin biosynthetic gene cluster of Streptomyces antibioticus and generation of new erythromycin derivatives. |
1999 |
Mol. Microbiol. |
pmid:10594828
|
Portillo A et al. |
Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10595574
|
Sugiyama Y et al. |
Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages. |
1999 |
Eur. Respir. J. |
pmid:10596699
|
Polk RE et al. |
Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy men. |
1999 |
Pharmacotherapy |
pmid:10600086
|
Esposito S et al. |
In vitro activity of moxifloxacin compared to other fluoroquinolones against different erythromycin-resistant phenotypes of group A beta-hemolytic streptococcus. |
2000 Jan-Feb |
Chemotherapy |
pmid:10601794
|
Ku YY et al. |
Synthesis and antibacterial activities of novel 12-O-methylerythromycin A derivatives. |
1999 |
J. Antibiot. |
pmid:10604761
|
Ianaro A et al. |
Anti-inflammatory activity of macrolide antibiotics. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10604943
|
Sato Y et al. |
Adjuvant effect of a 14-member macrolide antibiotic on DNA vaccine. |
1999 |
Cell. Immunol. |
pmid:10607432
|
Wang JS et al. |
Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro. |
1999 |
Pharmacol. Toxicol. |
pmid:10608481
|
Honein MA et al. |
Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study. |
1999 Dec 18-25 |
Lancet |
pmid:10609814
|
Czeizel AE et al. |
A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. |
1999 Nov-Dec |
Reprod. Toxicol. |
pmid:10613401
|
Chieppa DM et al. |
Effects of erythromycin on human colonic circular muscle in idiopathic chronic constipation. |
2000 |
Eur. J. Clin. Invest. |
pmid:10620004
|
Novikova SI et al. |
Introduction of a mini-gene encoding a five-amino acid peptide confers erythromycin resistance on Bacillus subtilis and provides temporary erythromycin protection in Proteus mirabilis. |
2000 |
FEMS Microbiol. Lett. |
pmid:10620668
|
Desaki M et al. |
Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10623585
|
Kdesh A et al. |
Effect of erythromycin on myocardial repolarization in patients with community-acquired pneumonia. |
1999 |
South. Med. J. |
pmid:10624910
|
GarcÃa Sánchez MJ et al. |
[Bacterial resistances]. |
1999 |
Aten Primaria |
pmid:10630037
|
Sullivan S et al. |
Stevens-Johnson syndrome secondary to erythromycin. |
1999 |
Ann Pharmacother |
pmid:10630839
|
Trinkle R |
Comment: evaluation of the clinical and financial impact of intravenous erythromycin therapy in hospitalized patients. |
1999 |
Ann Pharmacother |
pmid:10630842
|
Puri SK and Singh N |
Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys. |
2000 |
Exp. Parasitol. |
pmid:10631075
|
Weston WL and Morelli JG |
Steroid rosacea in prepubertal children. |
2000 |
Arch Pediatr Adolesc Med |
pmid:10632252
|
|
Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999. |
1999 |
MMWR Morb. Mortal. Wkly. Rep. |
pmid:10634345
|